Stem cell therapies, regenerative medicine, tissue engineering, and cellular reprogramming
170 articles
65-patient trial tested bone marrow stem cells injected directly into damaged heart muscle to restore function in chronic heart failure.
Study evaluates umbilical cord and placental tissues for cost-effective mesenchymal stem cell banking and regenerative medicine applications.
Small trial tests autologous stem cells to regenerate damaged knee cartilage in osteoarthritis patients with promising safety profile.
New delivery system combines stem cell vesicles with hydrogels to cross blood-brain barrier and treat neurological disorders.
New scaffolding systems deliver healing exosomes to stubborn wounds like diabetic ulcers, offering hope beyond conventional treatments.
New delivery systems dramatically improve stem cell survival and therapeutic effectiveness in tissue repair applications.
New research reveals that combining surgical debridement with exosome injections improved bone structure and reduced joint damage in arthritis.
Scientists created enhanced stem cell-derived particles that promote bone regeneration and reduce inflammation in periodontal disease.
New engineered vesicles called hybrosomes may overcome key limitations of exosome therapy for skin regeneration and anti-aging treatments.
New regenerative treatments using stem cells and growth factors significantly improve atrophic scars with minimal side effects.
Review reveals significant gaps between exosome therapy marketing and regulatory approval for pain treatment.
Scientists develop 3D bioprinting methods to mass-produce therapeutic exosomes, potentially transforming personalized medicine approaches.
